Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this research is to document normal intracranial venous sinus pressures. Participants who need to have a cerebral angiogram to evaluate a medical problem not related to Idiopathic Intracranial Hypertension (IIH) will be invited to participate. Participation in this research will not require any extra visits. The intervention will take place in the interventional radiology suite when the subject has an angiogram. IIH is a condition that causes increased pressure in the brain in the absence of a tumor or other diseases that may be causing symptoms. Symptoms include headaches and visual disturbances not explained by other things. In IIH there is a narrowing in the sinuses of the brain that causes the increased pressure.
Patients will be prospectively enrolled into the study. All adult patients, aged of 18-60, determined to be candidates for elective cerebral arteriography will be screened for inclusion in this study. Patients consenting to participate and enrolled in the study will first undergo their standard cerebral angiogram procedure, as clinically indicated. Once the procedure is completed, enrolled subjects will then undergo the study intervention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Venogram Group | Other | Participants in this group have a scheduled clinically indicated a cerebral angiogram procedure and will undergo a Venogram. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Venogram | Procedure | The 5 French (5F) diagnostic catheter will be navigated into the inferior then superior vena cava and then into the internal jugular bulb on the dominant venous side (as determined from the arteriographic images). Next, a 0.027 inch microcatheter will be navigated using fluoroscopic guidance into the superior sagittal sinus and a venogram will then performed by injecting a small dose of contrast. Next, the venous sinus pressure waveforms will be recorded as the catheter is withdrawn into the jugular bulb and then in the superior vena cava to obtain a central venous pressure. Once completed, the catheters will be removed and the sheaths will be removed. Manual pressure will be held at the venous access site for a few minutes. The arterial sheath will be closed based upon standard arteriogram protocol. |
| Measure | Description | Time Frame |
|---|---|---|
| Superior Sagittal Sinus Pressure | Superior sagittal sinus pressure will be recorded in mmHg as the catheter is withdrawn into the jugular bulb. | during venogram, up to 10 minutes |
| Torcula Sinus Pressure | Torcula sinus pressure will be recorded in mmHg as the catheter is withdrawn into the jugular bulb. | during venogram, up to 10 minutes |
| Dominant Transverse Sinus | Dominant transverse sinus will be recorded in mmHg as the catheter is withdrawn into the jugular bulb. | during venogram, up to 10 minutes |
| Dominant Transverse-Sigmoid Sinus Junction | dominant transverse-sigmoid sinus junction will be recorded in mmHg as the catheter is withdrawn into the jugular bulb. | during venogram, up to 10 minutes |
| Dominant Sigmoid Sinus | Dominant sigmoid sinus will be recorded in mmHg as the catheter is withdrawn into the jugular bulb. | during venogram, up to 10 minutes |
| Dominant Internal Jugular Vein | Dominant internal jugular vein will be recorded in mmHg as the catheter is withdrawn into the jugular bulb. | during venogram, up to 10 minutes |
| Central Venous Pressures | Central venous pressures will be recorded in mmHg as the catheter is withdrawn into the jugular bulb. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kimberly Hawley | Contact | 336-716-4031 | kimberly.hawley@advocatehealth.org | |
| Kyle Fargen, MD | Contact | kyle.fargen@advocatehealth.org |
| Name | Affiliation | Role |
|---|---|---|
| Kyle Fargen, MD | Wake Forest University Health Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Wake Forest Univesity Health Sciences | Recruiting | Winston-Salem | North Carolina | 27157 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Adult patients aged 18-60 years determined to be candidates for elective cerebral arteriography will be screened for inclusion in this study.
Not provided
Not provided
Not provided
Not provided
|
| during venogram, up to 10 minutes |